CERO(Delisted)
CERo TherapeuticsยทNASDAQ
--
--(--)
CERO Profile
Cero Therapeutics Holdings, Inc.
An innovative cancer immunotherapy company
201 Haskings Way, Suite 230, South San Francisco, CA 94080
--
CERo Therapeutics Holdings, Inc., was incorporated in Delaware on September 23, 2016. CERo is an innovative immunotherapy company driving the development of next-generation engineered T-cell therapies to treat cancer. Its proprietary T-cell engineering approach enables it to integrate certain ideal features of innate and adaptive immunity into a single therapeutic structure designed to mobilize the body's entire immune pool for optimized cancer therapy.
